Newsroom
300 articles
Featured With FDA’s continuous efforts to provide high standard healthcare system comes the next step of providing a fast adverse reporting system, this milestone reflects a pivotal advancement in…
Featured The Kingdom of Saudi Arabia has been working nonstop towards providing better healthcare solutions, keeping their promise of enhancing the healthcare sector as part of the Saudi Vision…
Featured The opioid epidemic, where almost one million Americans died due to improper use of opioids. Leading to the implementation of strict rules & changes in the labeling guide…
Featured People suffering from BCG-unresponsive non-muscle invasive bladder cancer now have a new hope with the recent approval of the Medicines and Healthcare Products Regulatory Agency (MHRA) of the…
Featured The Medicines and Healthcare Products Regulatory Agency (MHRA) granted approval for EURneffy, the first intranasal adrenaline (epinephrine) treatment for emergency management of anaphylaxis, offering a needle-free alternative to…
Featured Elinzanetant (Lynkuet) finally getting MHRA approval to provide relief for women suffering from menopausal symptoms. With Elinzanetant being the first non-hormonal therapy of its kind, works by modulating…
Featured The FDA just recently placed investigational measures on Sarepta Therapeutics new medication “Elevidys” that has been indicated for treatment patients suffering from Duchenne muscular dystrophy (DMD), after alarming…
Featured After deep review the EMA’s safety committee (PRAC) has decided on stopping the temporary restriction of people aged 65 years or older from getting the chikungunya vaccine. Nevertheless,…
Featured On July 2, 2025, the FDA gave accelerated approval to linvoseltamab-gcpt (Lynozyfic, Regeneron Pharmaceuticals, Inc.), a targeted therapy that helps the immune system attack cancer cells. It is…
Featured The Saudi food & drug authority has been actively working towards advancing public health in kingdom through ongoing strategic initiatives aimed at strengthening the healthcare system with the…
Featured Based on recent FDA findings the use of extended-release stimulants for ADHD management in children below 6 years old has been causing weight loss & other adverse events…
Featured As of 1st of July 2025 regulations associated with the use of radioactive substances or ionizing radiation has changed to ease the process for applications in order to…
Featured Patients fighting extensive stage small cell lung cancer (SCLC) now have new hope with UK’s Medicines and Healthcare products Regulatory Agency (MHRA) recently approving serplulimab (Hetronifly) a PD-1…
Featured The European Medicines Agency (EMA) has suggested granting provisional marketing authorization for Rezdiffra (resmetirom) the first treatment in the EU for noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with modest…
Featured With UK’s continuing efforts in providing better healthcare services & treatments for patients, comes the new initiative of providing at home cervical testing kits to screen for the…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP